Skip to main content
Premium Trial:

Request an Annual Quote

Leica Biosystems Bond RX Stainer

Leica Biosystems launched its Bond RX stainer. The instrument has customization options across all protocol editing systems allowing greater flexibility when optimizing conditions for tests based on immunofluorescence, in situ hybridization, fluorescence in situ hybridization, terminal deoxynucleotidyl transferase dUTP nick end labeling, thermal shift assay, circulating tumor cell, multiplexing, and other emerging tests, Leica said. Features of the instrument include protocol customization advancements, a reagent visual management lighting system, and a new software version 6.0.